The purpose of this study is to determine whether losartan, an angiotensin II blocker
prevents the sodium retention in patients with liver cirrhosis and by that reduces the fluid
retention. Moreover is the purpose to asses whether losartan is antifibrotic.
Phase:
Phase 4
Details
Lead Sponsor:
Odense University Hospital
Collaborators:
Else Poulsen Mindelegat Lundbeck Foundation University of Southern Denmark